Hyloris Partner Signs To Market Maxigesic IV In Central And Eastern Europe

Hyloris Has Also In-Licensed A Blood Mineral Deficiency Drug

Hyloris continues its European rollout for Maxigesic IV • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business